HomeRCE • ASX
add
Recce Pharmaceuticals Ltd
Previous close
$0.48
Day range
$0.46 - $0.47
Year range
$0.28 - $0.73
Market cap
133.02M AUD
Avg Volume
89.88K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 206.02K | -94.07% |
Operating expense | 3.01M | 7.03% |
Net income | -8.28M | -114.08% |
Net profit margin | -4.02K | -3,508.98% |
Earnings per share | — | — |
EBITDA | -7.82M | -123.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 365.26K | -81.21% |
Total assets | 2.04M | -51.48% |
Total liabilities | 20.66M | 124.71% |
Total equity | -18.62M | — |
Shares outstanding | 289.18M | — |
Price to book | -8.00 | — |
Return on assets | -962.08% | — |
Return on capital | 110.27% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.28M | -114.08% |
Cash from operations | -4.74M | -37.05% |
Cash from investing | 75.92K | 137.22% |
Cash from financing | -373.04K | -115.35% |
Net change in cash | -5.04M | -308.01% |
Free cash flow | -4.78M | -115.90% |
About
CEO
Founded
Apr 11, 2007
Website
